Dominique Heymann

What is he best known for?

The fields of study he is best known for:

• Gene
• Cancer
• Internal medicine

Dominique Heymann spends much of his time researching Osteoclast, RANKL, Cancer research, Internal medicine and Osteosarcoma. His studies deal with areas such as Stromal cell, Bone cell, Biophysics, Bone remodeling and Resorption as well as Osteoclast. Dominique Heymann works mostly in the field of RANKL, limiting it down to topics relating to Osteoprotegerin and, in certain cases, Immunology and Osteolysis, as a part of the same area of interest.

His studies in Cancer research integrate themes in fields like Cytokine, Cell growth, Cancer cell, Apoptosis and Single-cell analysis. His study in Endocrinology extends to Internal medicine with its themes. His Osteosarcoma research is included under the broader classification of Pathology.

His most cited work include:

• The molecular triad OPG/RANK/RANKL: involvement in the orchestration of pathophysiological bone remodeling. (470 citations)
• Osteoclastic resorption of calcium phosphate ceramics with different hydroxyapatite/β-tricalcium phosphate ratios (343 citations)
• Induction of Osteogenesis in Mesenchymal Stem Cells by Activated Monocytes/Macrophages Depends on Oncostatin M Signaling (271 citations)

What are the main themes of his work throughout his whole career to date?

Dominique Heymann mainly investigates Cancer research, Osteosarcoma, Pathology, Internal medicine and RANKL. His Cancer research research is multidisciplinary, incorporating elements of Cell culture, Cancer cell, Immunology, Tumor progression and In vivo. His study in Osteosarcoma is interdisciplinary in nature, drawing from both Osteolysis, Cell growth, Metastasis, Sarcoma and Primary bone.

Dominique Heymann combines subjects such as Endocrinology and Oncology with his study of Internal medicine. He has included themes like Osteoclast and Osteoprotegerin in his RANKL study. Dominique Heymann interconnects Bone cell, Cell biology and Bone remodeling in the investigation of issues within Bone resorption.

He most often published in these fields:

• Cancer research (49.30%)
• Osteosarcoma (45.27%)
• Pathology (25.35%)

What were the highlights of his more recent work (between 2017-2021)?

• Osteosarcoma (45.27%)
• Cancer research (49.30%)
• Cancer (11.27%)

In recent papers he was focusing on the following fields of study:

Osteosarcoma, Cancer research, Cancer, Cancer cell and Internal medicine are his primary areas of study. His Osteosarcoma research integrates issues from Cell culture, Osteolysis, Mesenchymal stem cell and Sarcoma. His study looks at the relationship between Osteolysis and topics such as Bone remodeling, which overlap with Bone resorption.

His work deals with themes such as Chemotherapy, Metastasis, Circulating tumor cell, microRNA and In vivo, which intersect with Cancer research. His Internal medicine research is multidisciplinary, incorporating perspectives in Endocrinology and Oncology. RANKL is closely connected to Tumor microenvironment in his research, which is encompassed under the umbrella topic of Osteoprotegerin.

Between 2017 and 2021, his most popular works were:

• The contribution of immune infiltrates and the local microenvironment in the pathogenesis of osteosarcoma. (54 citations)
• The contribution of immune infiltrates and the local microenvironment in the pathogenesis of osteosarcoma. (54 citations)
• The contribution of immune infiltrates and the local microenvironment in the pathogenesis of osteosarcoma. (54 citations)

In his most recent research, the most cited papers focused on:

• Gene
• Cancer
• Internal medicine

Dominique Heymann focuses on Osteosarcoma, Disease, Cancer, Cancer research and Circulating tumor cell. His research integrates issues of Tumor microenvironment, Chondrosarcoma, Sarcoma and RANKL in his study of Osteosarcoma. His Disease study is concerned with Internal medicine in general.

His work on Cancer cell and Acquired resistance is typically connected to Multidrug tolerance as part of general Cancer study, connecting several disciplines of science. His Cancer cell study also includes

• Extracellular matrix which is related to area like Immunology,
• Immune system which intersects with area such as Bioinformatics, Bone healing, Bone resorption, Bone remodeling and Regeneration. His Cancer research study combines topics in areas such as Oral administration, Chemotherapy, Doxorubicin, Osteoclast and Tumor initiation.